| scholarly article | Q13442814 |
| P50 | author | John Barnes | Q63633456 |
| Larisa Gubareva | Q66732793 | ||
| Margaret Okomo Adhiambo | Q69526781 | ||
| Alicia M Fry | Q87077992 | ||
| P2093 | author name string | Su Su | |
| Rebecca J Garten | |||
| Julie Hand | |||
| Ha T Nguyen | |||
| Julie M Villanueva | |||
| John Barnes | |||
| Xu Xiyan | |||
| Anwar Abd Elal | |||
| 2013–14 US Influenza Antiviral Working Group | |||
| Elizabeth Negron | |||
| P2860 | cites work | Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out? | Q28534984 |
| Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses | Q28541953 | ||
| Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. | Q30383771 | ||
| Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States | Q30399317 | ||
| Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. | Q30412554 | ||
| Glycosylation site alteration in the evolution of influenza A (H1N1) viruses | Q33987971 | ||
| Permissive secondary mutations enable the evolution of influenza oseltamivir resistance | Q34118992 | ||
| Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. | Q36048315 | ||
| Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. | Q36870919 | ||
| GISAID: Global initiative on sharing all influenza data - from vision to reality | Q42364268 | ||
| Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States | Q43185903 | ||
| Update: influenza activity--United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine | Q43643569 | ||
| Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012. | Q44616840 | ||
| Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. | Q45947329 | ||
| P433 | issue | 1 | |
| P921 | main subject | United States of America | Q30 |
| oseltamivir | Q211509 | ||
| P304 | page(s) | 136-141 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Emerging Infectious Diseases | Q5235761 |
| P1476 | title | Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14. | |
| P478 | volume | 21 |
| Q90240753 | A Dual-Functioning 5'-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1 |
| Q30390167 | A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro |
| Q36304783 | Addressing viral resistance through vaccines |
| Q30372845 | Altered viral replication and cell responses by inserting microRNA recognition element into PB1 in pandemic influenza A virus (H1N1) 2009. |
| Q36200716 | Antiviral Activities of Several Oral Traditional Chinese Medicines against Influenza Viruses |
| Q57815887 | Antiviral resistance markers in influenza virus sequences in Mexico, 2000-2017 |
| Q30395244 | Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment |
| Q35794372 | Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China |
| Q30371865 | Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan |
| Q26782746 | Clinical Implications of Antiviral Resistance in Influenza |
| Q64134362 | Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa |
| Q30380287 | Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase. |
| Q64057942 | Evolution and Biological Evaluation of Matrinic Derivatives with Amantadine Fragments As New Anti-Influenza Virus Agents |
| Q36347157 | Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015 |
| Q59357432 | Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development |
| Q95591446 | Influenza |
| Q26739661 | Influenza and the use of oseltamivir in children |
| Q33698075 | Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART |
| Q60958294 | Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant |
| Q38963385 | The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses |
| Q55447639 | The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics. |
| Q40768792 | Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from 2006 to 2012 in Catalonia, Spain. |
Search more.